耐受性
镇静
麻醉剂
医学
麻醉
疾病
不利影响
病理
药理学
作者
Muhammad Yousef,Diana Bharucha‐Goebel,Dimah Saade,G. Averion,Carsten G. Bönnemann,Zenaide M. N. Quezado
出处
期刊:A&A practice
[Wolters Kluwer]
日期:2021-10-01
卷期号:15 (10): e01539-e01539
标识
DOI:10.1213/xaa.0000000000001539
摘要
Giant axonal neuropathy (GAN) is a rare autosomal recessive neurodegenerative disorder caused by mutations in the GAN gene, which encodes for gigaxonin, a protein involved in intermediate filament processing in neural cells and fibroblasts. We report on 14 GAN patients who underwent 77 anesthetics during the conduct of an intrathecal gene transfer clinical trial from April 2015 to August 2020. We observed only a few nonsignificant perianesthetic complications. Our data expand the knowledge regarding safety of anesthesia for patients with this rare and potentially fatal disease and highlights the tolerability of shorter procedural sedation and anesthesia.
科研通智能强力驱动
Strongly Powered by AbleSci AI